Joseph M Mclung

No ORCID on file · 1 paper in corpus · active 2024
2024
·doi:10.1101/2024.04.12.589110

ABSTRACT Despite early optimism, therapeutics targeting oxidative phosphorylation (OxPhos) have faced clinical setbacks, stemming from their inability to distinguish healthy from cancerous mitochondria. Herein, we describe an actionable bi…